Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|March 12, 2013
Evaluation of complement-dependent cytotoxicity using ATP measurement and C1q/C4b bindingLucile Broyer, Liliane Goetsch, Matthieu BroussasMethods in Molecular Biology (Clifton, N.J.)|March 12, 2013
Evaluation of antibody-dependent cell cytotoxicity using lactate dehydrogenase (LDH) measurementMatthieu Broussas, Lucile Broyer, Liliane GoetschAntibodies (Basel, Switzerland)|September 24, 2019
Tumor-Directed Blockade of CD47 with Bispecific Antibodies Induces Adaptive Antitumor ImmunityElie Dheilly, Stefano Majocchi, Valéry Moine, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 4, 2017
Selective Blockade of the Ubiquitous Checkpoint Receptor CD47 Is Enabled by Dual-Targeting Bispecific AntibodiesElie Dheilly, Valéry Moine, Lucile Broyer, et al.Mabs|March 20, 2020
Targeting a membrane-proximal epitope on mesothelin increases the tumoricidal activity of a bispecific antibody blocking CD47 on mesothelin-positive tumorsEric Hatterer, Xavier Chauchet, Françoise Richard, et al.Journal of Hematology & Oncology|December 13, 2023
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancersAnja Seckinger, Sara Majocchi, Valéry Moine, et al.Nature Communications|February 13, 2015
Exploiting light chains for the scalable generation and platform purification of native human bispecific IgGNicolas Fischer, Greg Elson, Giovanni Magistrelli, et al.Molecular Cancer Therapeutics|May 11, 2018
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and LeukemiaVanessa Buatois, Zoë Johnson, Susana Salgado-Pires, et al.Pageof 1